To: President Ursula von der LeyenFirst Executive Vice-President Frans Timmermans Brussels, 29 March 2023 Dear President von der Leyen, Today was the scheduled date for the publication of the revised pharmaceutical legislation, an important piece of legislation of the...
Brussels, 9 March 2023 Dear Commissioner Kyriakides, We, the signatory organisations representing civil society, patients, consumers, and healthcare professionals, join other stakeholders in calling the European Commission to publish the proposed regulation and...
Brussels, 7 March 2023 Yesterday afternoon, the European Public Health Alliance (EPHA) and the European Patients’ Forum (EPF) were invited for an exchange of views with European Commission Vice-President Margaritis Schinas and Commissioner for Health and Food Safety...
EPHA participated in an online consultation and submitted comments to the WHO Europe on their recently launched multi-stakeholder Access to Novel Medicines Platform. The platform follows from the WHO Europe Oslo Medicines Initiative to which EPHA...
The transferable exclusivity voucher is a costly, complex and untested incentive for new antibiotics. It does not address access to new and old antibiotics, and it does not help with stewardship. We are worried that the European Commission plans to include the voucher...
